Standard BioTools Inc (NASDAQ: LAB) is -25.43% lower on its value in year-to-date trading and has touched a low of $1.21 and a high of $3.04 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The LAB stock was last observed hovering at around $1.31 in the last trading session, with the day’s loss setting it -0.01%.
Currently trading at $1.30, the stock is -19.34% and -26.47% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 3.06 million and changing -0.38% at the moment leaves the stock -33.93% off its SMA200. LAB registered -44.70% loss for a year compared to 6-month gain of -19.44%. The firm has a 50-day simple moving average (SMA 50) of $1.7832 and a 200-day simple moving average (SMA200) of $1.98075.
The stock witnessed a -19.94% loss in the last 1 month and extending the period to 3 months gives it a -40.14%, and is -10.62% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.76% over the week and 9.02% over the month.
Standard BioTools Inc (LAB) has around 539 employees, a market worth around $485.80M and $155.90M in sales. Profit margin for the company is -109.43%. Distance from 52-week low is 7.85% and -57.07% from its 52-week high. The company has generated returns on investments over the last 12 months (-32.95%).
with sales reaching $43.03M over the same period.The EPS is expected to grow by 62.06% this year, but quarterly earnings will post 60.99% year-over-year. Quarterly sales are estimated to grow 52.67% in year-over-year returns.
Standard BioTools Inc (LAB) Top Institutional Holders
194.0 institutions hold shares in Standard BioTools Inc (LAB), with institutional investors hold 72.68% of the company’s shares. The shares outstanding are 372.26M, and float is at 360.48M with Short Float at 3.70%. Institutions hold 71.33% of the Float.
The top institutional shareholder in the company is CASDIN CAPITAL, LLC with over 63.96 million shares valued at $113.21 million. The investor’s holdings represent 17.1782% of the LAB Shares outstanding. As of 2024-06-30, the second largest holder is VIKING GLOBAL INVESTORS LP with 58.65 million shares valued at $$103.81 million to account for 15.7524 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 21.75 million shares representing 5.8424% and valued at over $38.5 million, while VANGUARD GROUP INC holds 4.2981 of the shares totaling 16.0 million with a market value of $28.33 million.
Standard BioTools Inc (LAB) Insider Activity
#####
Still, SEC filings show that on Aug 27 ’24, Casdin Partners Master Fund, L (Director) acquired 250,000 shares at an average price of $2.19 for $0.55 million. The insider now directly holds 54,025,821 shares of Standard BioTools Inc (LAB).
